Related Experiment Video
Updated: Aug 23, 2025

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
Cefazolin-induced hypoprothrombinemia
Mallory Smith1, James Doyle1, Cameron Crane1
1Department of Internal Medicine, Baylor Scott & White Medical Center - Temple, Temple, Texas.
Abstract:
Long-term antibiotic use can be associated with a myriad of side effects, ranging from relatively benign to life-threatening. The most common side effects of cephalosporins include dermatologic reactions and diarrhea. Here, we present a rarer side effect: a spontaneous retroperitoneal hematoma in the setting of cefazolin administration for vertebral osteomyelitis. Several cephalosporins have been implicated in coagulopathy secondary to hypoprothrombinemia. However, only a few case reports have implicated cefazolin, and all have occurred in the context of acute or chronic renal failure. Our case of cefazolin-induced coagulopathy occurred in a patient with normal renal function.
Insights
Long-term antibiotic use, like cefazolin, can cause rare side effects. This case highlights spontaneous retroperitoneal hematoma in a patient with normal kidney function, a rare cefazolin-induced coagulopathy.
Area of Science:
- Pharmacology
- Internal Medicine
- Nephrology
Background:
- Long-term antibiotic therapy, particularly cephalosporins, is linked to diverse side effects.
- Common cephalosporin adverse events include dermatologic reactions and gastrointestinal disturbances.
- Antibiotic-induced coagulopathy, often due to hypoprothrombinemia, is a recognized but infrequent complication.
Observation:
- A rare case of spontaneous retroperitoneal hematoma is presented.
- This event occurred during cefazolin administration for vertebral osteomyelitis.
- The patient exhibited normal renal function at the time of the adverse event.
Findings:
- Cefazolin, a cephalosporin antibiotic, was implicated in causing coagulopathy.
- This contrasts with most reported cases of cefazolin-induced coagulopathy, which typically involve patients with renal impairment.
- The presented case expands the understanding of cefazolin's potential to induce bleeding complications even in patients with preserved kidney function.
Implications:
- Clinicians should be vigilant for rare bleeding complications associated with cefazolin, even in patients with normal renal function.
- This case underscores the importance of monitoring coagulation parameters in patients on long-term cefazolin therapy.
- Further research may be warranted to elucidate the precise mechanisms of cefazolin-induced coagulopathy in non-renal failure settings.
Related Concept Videos
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Parenteral Anesthetics: Overview
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...

